Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kazia Therapeutics (KZIA) Inventory (2009 - 2011)

Kazia Therapeutics (KZIA) posted Inventory of $298259.8 for Q4 2011, down 71.72% on a QoQ basis from $1.1 million in Q4 2010, and down 71.72% year-over-year from $1.1 million in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of Inventory data on file, last reported at $298259.8 in Q4 2011.

  • In Q4 2011, Inventory fell 71.72% year-over-year to $298259.8; the TTM figure through Dec 2011 stood at $298259.8 (down 71.72% YoY), while the FY2010 annual figure was $1.4 million, up 38.12% from the prior year.
  • Inventory eased to $298259.8 in Q4 2011, from $1.1 million in the prior quarter.
  • Across five years, Inventory topped out at $1.4 million in Q2 2010 and bottomed at $298259.8 in Q4 2011.
  • A 3-year average of $899428.8 and a median of $1.0 million in 2009 frame the typical range for Inventory.
  • Annual changes were most pronounced in 2010 — Inventory surged 40.32% — and 2011, when it slumped 71.72%.
  • Year by year, Inventory stood at $751703.4 in 2009, then soared by 40.32% to $1.1 million in 2010, then slumped by 71.72% to $298259.8 in 2011.
  • The last three Inventory figures came in at $298259.8 (Q4 2011), $1.1 million (Q4 2010), and $1.4 million (Q2 2010), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 84.03 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 298,259.82
Dec 31, 2010 1.05 Mn
Jun 30, 2010 1.38 Mn
Dec 31, 2009 751,703.38
Jun 30, 2009 1.01 Mn